These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22677529)

  • 1. Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.
    Li Y; Silamkoti A; Kolavi G; Mou L; Gulati S; Air GM; Brouillette WJ
    Bioorg Med Chem; 2012 Jul; 20(14):4582-9. PubMed ID: 22677529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Benzoic Acid Derivative NC-5 Against Influenza A Virus and Its Neuraminidase Inhibition.
    Guo M; Ni J; Yu J; Jin J; Ma L; Zhang H; Wang D; Zhang X; Dou J; Zhou C
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hydrophobic side chain of oseltamivir influences type A subtype selectivity of neuraminidase inhibitors.
    Lin X; Qin-Hua C; Peng L; Chun-Lei L; Guang-De Y
    Chem Biol Drug Des; 2018 Jan; 91(1):105-115. PubMed ID: 28646621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.
    Lin CH; Chang TC; Das A; Fang MY; Hung HC; Hsu KC; Yang JM; von Itzstein M; Mong KK; Hsu TA; Lin CC
    Org Biomol Chem; 2013 Jun; 11(24):3943-8. PubMed ID: 23695381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activity.
    Lew W; Wu H; Chen X; Graves BJ; Escarpe PA; MacArthur HL; Mendel DB; Kim CU
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1257-60. PubMed ID: 10866394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
    Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
    Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
    Kim CU; Lew W; Williams MA; Wu H; Zhang L; Chen X; Escarpe PA; Mendel DB; Laver WG; Stevens RC
    J Med Chem; 1998 Jul; 41(14):2451-60. PubMed ID: 9651151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors.
    Suzuki K; Koyama T; Yingsakmongkon S; Suzuki Y; Hatano K; Matsuoka K
    Bioorg Med Chem; 2012 Jan; 20(1):446-54. PubMed ID: 22100261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
    PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.
    Zhang H; Wang K; Zhu H; Zhao X; Zhao H; Lei Z; Chen B; Yang F; Liu K; Zhang K; Wang J; Tian Y
    Eur J Med Chem; 2020 Aug; 200():112423. PubMed ID: 32512482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6.
    Venkatramani L; Johnson ES; Kolavi G; Air GM; Brouillette WJ; Mooers BH
    BMC Struct Biol; 2012 May; 12():7. PubMed ID: 22559154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus.
    Márquez-Domínguez L; Reyes-Leyva J; Herrera-Camacho I; Santos-López G; Scior T
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32947893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.
    Li W; Xia L; Hu A; Liu A; Peng J; Tan W
    Arch Pharm (Weinheim); 2013 Sep; 346(9):635-44. PubMed ID: 23926081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.
    Sriwilaijaroen N; Wilairat P; Hiramatsu H; Takahashi T; Suzuki T; Ito M; Ito Y; Tashiro M; Suzuki Y
    Virol J; 2009 Aug; 6():124. PubMed ID: 19678928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase from Influenza A and B Viruses is Susceptible to the Compound 4-(4-Phenyl-1H-1,2,3-Triazol-1-yl)-2,2,6,6-Tetramethylpiperidine-1- Oxyl.
    Sacramento CQ; Jordão AK; Abrantes JL; Alves CM; Marttorelli A; Fintelman-Rodrigues N; de Freitas CS; de Melo GR; Cunha AC; Ferreira VF; Souza TML
    Curr Top Med Chem; 2020; 20(2):132-139. PubMed ID: 31880262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of crenatoside analogues as novel influenza neuraminidase inhibitors.
    Chen BL; Wang YJ; Guo H; Zeng GY
    Eur J Med Chem; 2016 Feb; 109():199-205. PubMed ID: 26774928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors.
    Das A; Adak AK; Ponnapalli K; Lin CH; Hsu KC; Yang JM; Hsu TA; Lin CC
    Eur J Med Chem; 2016 Nov; 123():397-406. PubMed ID: 27487569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.